// App-Quantinova.ai

TCT-321 : Definite and probable stent thrombosis after revascularization with drug-eluting stents with a biodegradable polymer. From the randomized SORT OUT VII Trial

Researchers

Presenter

  • Lisette Okkels Jensen

Principal Investigators

  • Michael Maeng

  • Bent Raungaard

  • Knud Noerregaard Hansen

  • Johnny Kahlert

  • Svend Eggert Jensen

  • Hans Erik Botker

  • Henrik Hansen

  • Jens Flensted Lassen

  • Evald Christiansen

Medical Centers

  • Zealand University Hospital, Aarhus N, Denmark

  • Odense University Hospital, Odense, Denmark

  • Odense University Hospital, Odense, Denmark

  • Aarhus University Hospital, Aarhus, Denmark

  • Heart Center, Rigshospitalet, Copenhagen, Denmark

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Rapacan

  • Crofelemer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved